Targeting the GRP78 Pathway for Cancer Therapy

69Citations
Citations of this article
51Readers
Mendeley users who have this article in their library.

Abstract

The 78-kDa glucose-regulated protein (GRP78) plays an important part in maintaining protein stability, regulating protein folding, and inducing apoptosis autophagy, which is considered as a powerful protein. Meanwhile, it also plays a role in ensuring the normal function of organs. In recent years, more and more researches have been carried out on the targeted therapy of GRP78, mainly focusing on its relevant role in tumor and its role as a major modulator and modulator of subordinate pathways. The ability of GRP78 to respond to endoplasmic reticulum stress (ERS) determines whether tumor cells survive and whether the changes in expression level of GRP78 regulated by endoplasmic reticulum (ER) caused by various factors will directly or indirectly affect cell proliferation, apoptosis, and injury, or reduce the body's defense ability, or have protective effects on various organs.

Cite

CITATION STYLE

APA

Lu, G., Luo, H., & Zhu, X. (2020, July 30). Targeting the GRP78 Pathway for Cancer Therapy. Frontiers in Medicine. Frontiers Media S.A. https://doi.org/10.3389/fmed.2020.00351

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free